CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Immunic to Participate in Investor Conferences in March

ConferenceNeutral
AI Analysis

Summary

Immunic announced its participation in investor conferences scheduled for March 2026. The company is a late-stage biotech developing novel oral therapies for neurologic and gastrointestinal diseases.

Importance:2/10
Sentiment:
0.00
investor_conferenceneurologic_diseasesgastrointestinal_diseasesoral_therapies
Related Companies

Read the original article

Published by PR Newswire Biotech on March 3, 2026 11:30 AM

Read Original